Terlipressin

CAS No.: 14636-12-5

Terlipressin Chemical Structure

Molecular formula: C₅₂H₇₄N₁₆O₁₅S₂

Molecular weight: 1227. 37

Patent period: —

Strengths: —

Injection : —

Oral tablets: —

Injection: —

Get in touch Download

Products are for laboratory research use only. Not for human use. We do not sell to patients.

Biological Activity

Terlipressin is a synthetic analogue of vasopressin used to treat hypotension. It may be beneficial when epinephrine proves ineffective. Indications include septic shock and hepatorenal syndrome unresponsive to epinephrine, as well as bleeding from ruptured esophageal varices.

This medication is marketed in the United States, New Zealand, Australia, India, Pakistan, Taiwan, and other regions.

Chemical Properties

CAS NO.	14636-12-5
FORMULA	C₅₂H₇₄N₁₆O₁₅S₂
M. WT	1227. 37
PURITY	—
SMILES	O=C ([C@H] (CSSC[C@@H] (C (N[C@H] (C1=O) CC2=CC=C (O) C=C2) =O) NC (CNC (CNC (CN) =O) =O) =O) NC ([C@@H] (NC ([C@@H] (NC ([C@] (N1) ([H]) CC3=CC=CC=C3) =O) CCC (N) =O) =O) CC (N) =O) =O) N (CCC4) [C@@H]4C (N[C@@H] (CCCCN) C (NCC (N) =O) =O) =O
STORAGE	Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for 36 months. In solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Online Inquiry

Cardiovascular Disease

According to the terminal and pharmacy terminal data of Yao Rongyun Hospital, the scale of cardiovascular chemical drugs in China was close to 90 billion yuan in 2021, and the hospital terminals accounted for 74%.

Other Drug Peptide More+

Linaclotide new

Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.
Thymalfasin

Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide.
Atosiban

Atosiban is a peptide Oxytocin Receptor Inhibitor. Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra) . Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells and reduced influx of Ca2+ from the extracellular space through voltage-gated channels occur. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
Tesamorelin

EGRIFTA is a growth hormone releasing factor (GRF) analogindicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy:

Product Catalog

Terlipressin

GUIZHOU MTPEPTIDES BIOTECHNOLOGY CO., LTD